Skip to Content
Merck
All Photos(3)

Key Documents

YSC1

Sigma-Aldrich

Yeast from Saccharomyces cerevisiae

Type I

Synonym(s):

(Bakers yeast)

Sign Into View Organizational & Contract Pricing


About This Item

UNSPSC Code:
12352202
NACRES:
NA.81

biological source

Saccharomyces cerevisiae

type

Type I

form

powder or solid

application(s)

food and beverages
microbiology

storage temp.

2-8°C

General description

Yeast from Saccharomyces cerevisiae (Baker′s yeast) is the oldest microbial starter. It is a facultative anaerobe.

Application

Yeast from Saccharomyces cerevisiae has been used:
  • as a biocatalyst for the anode of yeast microbial fuel cell
  • for the production of ethanol for fuel use
  • to prepare yeast extract

Biochem/physiol Actions

Yeast from Saccharomyces cerevisiae (Baker′s yeast) is used as a protein supplement, energy booster and immune enhancer. It serves as a dough leavening agent in bread production by converting the fermentable sugars to CO2 and ethanol. Baker′s yeast exhibits aroma, anti-molding and nutritive properties. It acts as a cell factory.

Caution

Autolyzes in aqueous buffer at 37 °C.

Preparation Note

Dried to avoid inactivation of enzymes.

Storage Class Code

11 - Combustible Solids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Personal Protective Equipment

dust mask type N95 (US), Eyeshields, Gloves

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Engineering baker?s yeast: room for improvement
Randez-Gil F, et al.
Trends in biotechnology, 17(6), 237-244 (1999)
Zachariah P G Olufs et al.
Scientific reports, 8(1), 2348-2348 (2018-02-07)
Genetic variability affects the response to numerous xenobiotics but its role in the clinically-observed irregular responses to general anesthetics remains uncertain. To investigate the pharmacogenetics of volatile general anesthetics (VGAs), we developed a Serial Anesthesia Array apparatus to expose multiple
Miniature flowing atmospheric-pressure afterglow ion source for facile interfacing of CE with MS
Jecklin MC, et al.
Electrophoresis, 31(21), 3597-3605 (2010)
Inventions on baker's yeast strains and specialty ingredients
Gelinas P
Recent Patents on Food, Nutrition & Agriculture, 1(2), 104-132 (2009)
Brewer's/baker's yeast (Saccharomyces cerevisiae) and preventive medicine: Part II
Moyad MA
Urologic Nursing, 28(1), 73-75 (2008)

Protocols

This procedure may be used for the determination of Lyticase activity using Baker’s yeast as the substrate.

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service